South Africa introduces first generic semaglutide injection to address market demand

South Africa has launched its first generic semaglutide injection, aiming to increase competition and reduce costs for GLP-1 weight loss treatments. It remains uncertain whether these generics will achieve price points low enough to eliminate the illicit black market or facilitate access for public-sector patients.